This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liszewski, M. K. et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39, 1143–1157 (2013).
Arbore, G. et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science 352, aad1210 (2016).
Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42, 1033–1047 (2015).
West, E. E., Kolev, M. & Kemper, C. Complement and the regulation of T cell responses. Annu. Rev. Immunol. 36, 309–338 (2018).
Ellinghaus, U. et al. Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus. Eur. J. Immunol. 47, 1200–1210 (2017).
Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685–1699 (2017).
Kurasawa, K. et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43, 2455–2463 (2000).
Radstake, T. R. et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS ONE 4, e5903 (2009).
Kordasti, S. et al. Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment. Blood 128, 1193–1205 (2016).
Povoleri, G. A. M. et al. Human retinoic acid-regulated CD161(+) regulatory T cells support wound repair in intestinal mucosa. Nat. Immunol. 19, 1403–1414 (2018).
Acknowledgements
We thank the patients and the healthy donors for their support. This work was financed by MRC Centre grant MR/J006742/1, an EU-funded Innovative Medicines Initiative BTCURE (C.K.), a Wellcome Trust Investigator Award (C.K.), the King’s Bioscience Institute at King’s College London (G.A.), The King’ College London BRC Genomics Facility, the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, National Institute Of Health grant R21 AI123789 (D.E.H.) and by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH (C.K.). D.E.H. and L.M. are grateful for the support of the Washington University School of Medicine Immunomonitoring Laboratory. V.H.O., C.P.D. and D.A. are grateful for funding support from Versus Arthritis, Scleroderma & Raynaud’s UK, Rosetrees Trust and Royal Free Charity. T.M.W. is supported by a National Health and Medical Research Council Fellowship (1105420). SK is supported by Cancer Research UK (CRUK). The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Center awarded to Guy’s & St Thomas’ NHS Foundation Trust in Partnership with King’s College London and King’s College Hospital NHS Foundation Trust.
Author information
Authors and Affiliations
Contributions
D.E.H, C.K. and S.K. conceived and directed the study, performed experiments and wrote the manuscript. G.A., B.C., L.P., T.M.W. and C.K. designed, performed and/or analyzed the T-cell activation and ‘rescue’ experiments. L.M., R.E., S.H., S.K., K.B. and P.N., generated and validated the heavy metal-conjugated CyTOF® compatible antibody panel and/or performed and/or analyzed the CyTOF experiments. V.H.O., D.A., and C.P.D. designed and analyzed the experiments and data derived from cells isolated from the patients. All authors discussed and edited the manuscript. G.A. and V.H.O. contributed equally to the work and are shared first authors.
Corresponding authors
Ethics declarations
Competing interests
T.M.W. is a co-inventor on a patent for C5aR2 agonists as immunomodulators for inflammatory disease. The authors have no additional financial interests.
Rights and permissions
About this article
Cite this article
Arbore, G., Ong, V.H., Costantini, B. et al. Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis. Cell Mol Immunol 17, 1010–1013 (2020). https://doi.org/10.1038/s41423-019-0360-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-019-0360-8
This article is cited by
-
Canonical and non-canonical roles of complement in atherosclerosis
Nature Reviews Cardiology (2024)